Insufficient scRNA-seq data for expression of FCGR2C at single-cell level.
Insufficient scRNA-seq data for expression of FCGR2C at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 1211.10 | 570 / 578 | 78% | 3.71 | 898 / 1155 |
breast | 87% | 643.42 | 400 / 459 | 84% | 3.69 | 941 / 1118 |
thymus | 89% | 503.91 | 583 / 653 | 57% | 1.51 | 347 / 605 |
skin | 61% | 285.37 | 1095 / 1809 | 78% | 11.93 | 367 / 472 |
esophagus | 87% | 563.35 | 1253 / 1445 | 46% | 1.41 | 85 / 183 |
kidney | 53% | 254.83 | 47 / 89 | 76% | 4.10 | 686 / 901 |
bladder | 86% | 343.81 | 18 / 21 | 42% | 1.54 | 212 / 504 |
intestine | 94% | 793.96 | 910 / 966 | 32% | 0.80 | 167 / 527 |
uterus | 70% | 255.18 | 119 / 170 | 54% | 1.43 | 246 / 459 |
adrenal gland | 91% | 791.80 | 236 / 258 | 21% | 0.44 | 48 / 230 |
pancreas | 34% | 94.98 | 112 / 328 | 78% | 3.07 | 139 / 178 |
ovary | 47% | 172.04 | 85 / 180 | 63% | 2.00 | 270 / 430 |
spleen | 100% | 1090.58 | 241 / 241 | 0% | 0 | 0 / 0 |
stomach | 53% | 244.04 | 192 / 359 | 46% | 1.53 | 131 / 286 |
adipose | 98% | 1480.50 | 1176 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 872.57 | 884 / 929 | 0% | 0 | 0 / 0 |
prostate | 68% | 286.47 | 166 / 245 | 24% | 0.45 | 122 / 502 |
blood vessel | 83% | 601.91 | 1113 / 1335 | 0% | 0 | 0 / 0 |
heart | 80% | 459.18 | 685 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 62% | 1.46 | 28 / 45 |
liver | 29% | 85.61 | 66 / 226 | 25% | 1.00 | 100 / 406 |
brain | 15% | 62.01 | 402 / 2642 | 38% | 1.78 | 268 / 705 |
lymph node | 0% | 0 | 0 / 0 | 45% | 2.02 | 13 / 29 |
muscle | 39% | 109.13 | 317 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 15% | 0.26 | 12 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006955 | Biological process | immune response |
GO_0050766 | Biological process | positive regulation of phagocytosis |
GO_0001788 | Biological process | antibody-dependent cellular cytotoxicity |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0038094 | Biological process | Fc-gamma receptor signaling pathway |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0019864 | Molecular function | IgG binding |
GO_0019770 | Molecular function | IgG receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FCGR2C |
Protein name | Low affinity immunoglobulin gamma Fc region receptor II-c (IgG Fc receptor II-c) (CDw32) (Fc-gamma RII-c) (Fc-gamma-RIIc) (FcRII-c) (CD antigen CD32) |
Synonyms | IGFR2 FCG2 CD32 |
Description | FUNCTION: Receptor for the Fc region of complexed immunoglobulins gamma. Low affinity receptor. Involved in a variety of effector and regulatory functions such as phagocytosis of immune complexes and modulation of antibody production by B-cells. |
Accessions | P31995 |